Chu Amiens Sud

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Chronic lymphocytic leukaemia1 trial
• Endometriosis1 trial
• Lung cancer1 trial
• Multiple myeloma1 trial

Phase

• Phase 21 trial

Status

• Active, not recruiting2 trials
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Assistance Publique - Hôpitaux de Paris1 trial
• French Innovative Leukemia Organisation1 trial
• Intergroupe Francophone du Myelome1 trial
• Pfizer1 trial

Running trials

• Not yet recruiting

  ActiTENS Mini (Transcutaneous Electrical Stimulation) in Women With Chronic Pain From Pelvic Endometriosis

  NCT07317037· Assistance Publique - Hôpitaux de Paris· Source

  Contact: FOULON ARTHUR

• Recruiting

  Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context

  NCT06487078· Pfizer· Source

• Active, not recruiting

  Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations.

  NCT04144387· Intergroupe Francophone du Myelome· Source

• Active, not recruiting

  Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction

  NCT03734198· Phase 2· French Innovative Leukemia Organisation· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Endometriosis1 recruiting
• Lung cancer1 recruiting